"Mutation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.
| Descriptor ID |
D009154
|
| MeSH Number(s) |
G05.365.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mutation".
Below are MeSH descriptors whose meaning is more specific than "Mutation".
This graph shows the total number of publications written about "Mutation" by people in this website by year, and whether "Mutation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 4 | 5 |
| 1996 | 1 | 5 | 6 |
| 1997 | 3 | 7 | 10 |
| 1998 | 1 | 3 | 4 |
| 1999 | 0 | 10 | 10 |
| 2000 | 3 | 10 | 13 |
| 2001 | 3 | 7 | 10 |
| 2002 | 5 | 9 | 14 |
| 2003 | 2 | 22 | 24 |
| 2004 | 5 | 19 | 24 |
| 2005 | 3 | 19 | 22 |
| 2006 | 6 | 27 | 33 |
| 2007 | 3 | 14 | 17 |
| 2008 | 3 | 15 | 18 |
| 2009 | 5 | 20 | 25 |
| 2010 | 8 | 20 | 28 |
| 2011 | 12 | 19 | 31 |
| 2012 | 7 | 21 | 28 |
| 2013 | 2 | 22 | 24 |
| 2014 | 6 | 17 | 23 |
| 2015 | 6 | 20 | 26 |
| 2016 | 18 | 19 | 37 |
| 2017 | 13 | 30 | 43 |
| 2018 | 4 | 23 | 27 |
| 2019 | 6 | 16 | 22 |
| 2020 | 10 | 28 | 38 |
| 2021 | 11 | 30 | 41 |
| 2022 | 0 | 11 | 11 |
| 2023 | 0 | 11 | 11 |
| 2024 | 2 | 5 | 7 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mutation" by people in Profiles.
-
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic. Nat Microbiol. 2025 Jan; 10(1):77-93.
-
Spontaneous mutation in 2310061I04Rik results in reduced expression of mitochondrial genes and impaired brain myelination. PLoS One. 2024; 19(12):e0290487.
-
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G. Oncologist. 2024 Aug 05; 29(8):723-e1093.
-
Directed evolution of material-producing microorganisms. Proc Natl Acad Sci U S A. 2024 Jul 30; 121(31):e2403585121.
-
Low- and High-Grade Glioma-Associated Vascular Cells Differentially Regulate Tumor Growth. Mol Cancer Res. 2024 Jul 02; 22(7):656-667.
-
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170). Cancer Res Commun. 2024 07 01; 4(7):1793-1801.
-
Chordoma: Genetics and Contemporary Management. Int J Mol Sci. 2024 May 28; 25(11).
-
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors. Clin Cancer Res. 2024 May 01; 30(9):1739-1749.
-
ROM1 is redundant to PRPH2 as a molecular building block of photoreceptor disc rims. Elife. 2023 Nov 22; 12.
-
Hereditary Thrombotic Thrombocytopenic Purpura. Genes (Basel). 2023 10 18; 14(10).